The antiserum was produced against synthesized peptide derived between 136-185 amino acids from the Internal region of human CDK7 around the phosphorylation site of Thr170.
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using CDK7 (Phospho-Thr170) Antibody. The picture on the right is treated with the synthesized peptide.
HeLa cells
Western blot analysis of extracts from HeLa cells treated with Calyculin A 50nM 30', using CDK7 (Phospho-Thr170) Antibody. The lane on the right is treated with the synthesized peptide.